Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a digital consumer healthcare platform that connects patients with licensed healthcare professionals and fulfillment services. The company provides personalized access to prescription medications, compounded treatments, and over-the-counter wellness products focusing on areas such as sexual health, hair loss, dermatology, mental health, and weight management. Additionally, it offers comprehensive laboratory testing and health assessment services directly through its websites and mobile applications, serving consumers primarily on a recurring subscription model.

The company operates across the United States, Canada, the United Kingdom, and parts of the European Union, including Germany, France, Spain, and the Republic of Ireland. Fulfillment and manufacturing operations include two domestic pharmacies, two facilities licensed in the United Kingdom, an outsourcing facility, a peptide facility, and a laboratory center. The provided text details operations across these international regions without stating a specific headquarters location.

Summary of the business section of Hims & Hers Health's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“Our number of employees has also increased significantly over the last few years, from 1,046 employees as of December 31, 2023 to 2,442 employees as of December 31, 2025.”